Literature DB >> 16316961

Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy.

Margo A Denke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16316961     DOI： 10.1161/CIRCULATIONAHA.105.588178

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.

Authors:  M-R Taskinen; P J Barter; C Ehnholm; D R Sullivan; K Mann; J Simes; J D Best; S Hamwood; A C Keech
Journal:  Diabetologia       Date:  2010-06-06       Impact factor: 10.122

2.  Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.

Authors:  P Liting; L Guoping; C Zhenyue
Journal:  Herz       Date:  2014-11-07       Impact factor: 1.443

3.  Atherogenic indices in pseudoexfoliation syndrome.

Authors:  Enver Mirza
Journal:  Eye (Lond)       Date:  2019-07-05       Impact factor: 3.775

4.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

5.  Atherogenic indices in non-arteritic ischemic optic neuropathy.

Authors:  Nurullah Koçak; Volkan Yeter; Mustafa Turunç; Merve Bayrambaş; Bilge Eraydın; İnci Güngör
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

6.  Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Authors:  Michel P Hermans; Frank M Sacks; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2011-02-28       Impact factor: 9.951

7.  Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus on obesity, diet and alcohol intake.

Authors:  Gianluca Tognon; Christina Berg; Kirsten Mehlig; Dag Thelle; Elisabeth Strandhagen; Jaana Gustavsson; Annika Rosengren; Lauren Lissner
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

8.  Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM.

Authors:  Michel P Hermans; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2013-02-27       Impact factor: 9.951

Review 9.  Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.

Authors:  Sven-Olof Olofsson; Olov Wiklund; Jan Borén
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese.

Authors:  Weiwei Zhao; Wei Gong; Nan Wu; Yintao Li; Kuanping Ye; Bin Lu; Zhaoyun Zhang; Shen Qu; Yiming Li; Yehong Yang; Renming Hu
Journal:  Lipids Health Dis       Date:  2014-02-20       Impact factor: 3.876
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.